NUCB2 and renal carcinoma: Mechanistically, it has been shown that NUCB2/nesfatin-1 improved the migration, invasion, and EMT characteristics of colon and renal cancer cells through stimulation of the AMPK/TOC1/ZEB1 pathway [12, 13].